Is the FDA contributing to the homelessness crisis?




The FDA’s REMS program has been found to have unintentionally created barriers to accessing clozapine, a crucial antipsychotic drug for treatment-resistant schizophrenia, leading to tragic stories of relapses and suicide attempts.



Source link

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe

Latest Articles